AbCellera Biologics Inc.
11.05USD
-0.3900 (-3.41%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.17▲ | $-0.18 | 1 | 0 |
| Next quarter | $-0.17▲ | $-0.18 | 2 | 1 |
| Current year | $-0.66▲ | $-0.66 | 1 | 3 |
| Next year | $-0.72▲ | $-0.72 | 2 | 1 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.17 | $-0.18 | -0.01 (-9.1%) |
| 2026-03-31 | $-0.2 | $-0.14 | +0.06 (+29.1%) |
| 2025-12-31 | $-0.18 | $-0.03 | +0.15 (+83.3%) |
| 2025-09-30 | $-0.16 | $-0.19 | -0.03 (-17.3%) |
50 ratings from 14 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $12 $30 | Aug 11, 2026 |
| Stifel | Maintained | Buy | $8 $9 | Aug 6, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $11 $12 | Aug 6, 2026 |
| Benchmark | Upgraded from Hold | Buy | $11 | Jul 7, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | $7 | May 5, 2026 |
| Jones Trading | Initiated | Buy | $11 | Apr 10, 2026 |
| Leerink Partners | Downgraded from Outperform | Market Perform | $4 | Nov 7, 2025 |
| Stifel | Maintained | Buy | $8 $7 | Aug 8, 2025 |
| Keybanc | Maintained | Overweight | $5 $10 | Jul 14, 2025 |
| Truist Securities | Maintained | Buy | $28 $10 | May 16, 2025 |
| Stifel | Maintained | Buy | $10 $8 | May 9, 2025 |
| Keybanc | Maintained | Overweight | $4 $5 | Apr 16, 2025 |
| Benchmark | Reiterated | Hold | — | Mar 3, 2025 |
| Stifel | Maintained | Buy | $12 $10 | Feb 28, 2025 |
| Keybanc | Maintained | Overweight | $5 $4 | Jan 8, 2025 |
| Benchmark | Reiterated | Hold | — | Nov 5, 2024 |
| Stifel | Reiterated | Buy | $14 $12 | Nov 5, 2024 |
| Benchmark | Downgraded from Buy | Hold | — | Aug 20, 2024 |
| Keybanc | Maintained | Overweight | $7 $5 | Jul 11, 2024 |
| Keybanc | Maintained | Overweight | $8 $7 | May 8, 2024 |
| Benchmark | Upgraded from Hold | Buy | — | Feb 22, 2024 |
| Stifel | Maintained | Buy | $21 $17 | Feb 21, 2024 |
| Keybanc | Initiated | Overweight | $6 | Dec 5, 2023 |
| Benchmark | Maintained | Buy | $20 $12 | Aug 31, 2023 |
| Goldman Sachs | Maintained | Buy | $27 $24 | Aug 4, 2023 |
19 filings from 5 insiders · 0 buy / 0 sell over 6m
Officers and directors of ABCL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HAYDEN MICHAEL REUBENDirector | Buyindirect | 53.6k | $10.64 | $570k | Aug 24, 2026 |
| MONTALBANO JOHN S.Director | Buy | 10.0k | $11.03 | $110k | Aug 18, 2026 |
| BOOTH ANDREWChief Financial Officer | Buy | 37.2k | $10.32 | $384k | Aug 14, 2026 |
| HAYDEN MICHAEL REUBENDirector | Buyindirect | 46.4k | $10.37 | $481k | Aug 12, 2026 |
| HAYDEN MICHAEL REUBENDirector | Giftindirect | 50.0k | — | — | Aug 11, 2026 |
| BOOTH ANDREWChief Financial Officer | Exercise | 250.0k | $0.19 | $48k | Jun 3, 2026 |
| MONTALBANO JOHN S.Director | Buy | 20.0k | $4.77 | $95k | May 14, 2026 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Buy | 38.0k | $3.44 | $131k | Feb 27, 2026 |
| BOOTH ANDREWChief Financial Officer | Buy | 42.6k | $3.42 | $146k | Feb 27, 2026 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Buy | 177.5k | $3.27 | $580k | Feb 26, 2026 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Gift | 225.0k | — | — | Dec 18, 2025 |
| MONTALBANO JOHN S.Director | Buy | 50.0k | $3.57 | $178k | Nov 26, 2025 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Buy | 343.6k | $2.16 | $742k | Mar 11, 2025 |
| MONTALBANO JOHN S.Director | Buy | 25.0k | $2.30 | $58k | Mar 10, 2025 |
| MONTALBANO JOHN S.Director | Buy | 60.0k | $2.34 | $141k | Mar 6, 2025 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Gift | 286.0k | — | — | Dec 4, 2024 |
| HANSEN CARL L.G.Chief Executive Officer | Exercise | 56.1k | $2.70 | $152k | Nov 25, 2024 |
| HANSEN CARL L.G.Chief Executive Officer | Exercise | 56.1k | $2.70 | $152k | Sep 20, 2024 |
| THERMOPYLAE HOLDINGS, LTD.Beneficial Owner of more than 10% of a Class of Security | Buy | 283.5k | $2.61 | $740k | Aug 29, 2024 |
No analyst notes on ABCL yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 8 | 0 | 0 | 0 | Buy1.89 |
| 1 mo ago | 1 | 8 | 0 | 0 | 0 | Buy1.89 |
| 2 mo ago | 1 | 8 | 0 | 0 | 0 | Buy1.89 |
| 3 mo ago | 1 | 7 | 1 | 0 | 0 | Buy2.00 |